Effect of More Expedited Carotid Intervention on Recurrent Events

This study shows the benefit of reducing waiting time between acute events and intervention in patients with severe symptomatic carotid stenosis. Its outcomes support the efforts to reduce patient management. Moreover, it could be used as an indicator of clinical practice quality.

Claves para mejorar la productividad en la sala de cateterismoThe risk of recurrent events after an ischemic event is significantly higher in the early phase because of extracranial carotid stenosis, which is why guidelines recommend a short delay (to perform either endarterectomy or stenting).

 

Data on all endarterectomy and all stenting on symptomatic stenosis patients were obtained from the Swedish Vascular Registry between 2008 and 2015. Data included all secondary events occurring after the presenting event up to 30 days follow up with inclusion of all pre- and post-intervention recurrences.


Read also: Safety of Early Carotid Artery Stenting in Symptomatic Patients.


Primary end point was recurrent cerebral ischemic event occurring after the presenting event up to 30 days of post-operative follow up.

 

The study looked at 6814 patients and showed a reduction of recurrent ischemic events (31% in 2008/09 to 21% in 2014/15; p=0.01) and, in parallel, mean time from index event to intervention was reduced from 13 to 7 days.


Read also: Is Stage 1 Hypertension as Defined in ACC/AHA Guidelines Associated with Any Events?


The proportion of recurrent events during waiting time was reduced from 25% to 18% (p<0.01) while periprocedural events (death and stroke) were 3.6%, and improved slightly during the studied period.

Conclusion

A substantial reduction of recurrent events is observed when mean waiting time between index procedure and intervention (endarterectomy or stenting) is reduced. This reduction of events during waiting time is in no way counterbalanced by an increase in periprocedural events.

Original title: Effect of More Expedited Carotid Intervention on Recurrent Ischaemic Event Rate: A National Audit.

Reference: Björn Kragsterman et al. Eur J Vasc Endovasc Surg (2018), article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...